In this free webinar, learn how a decentralized or hybrid
approach brings clinical trials to the patients, improving patient
enrollment and diversity. Gain insights into the patient-centric
benefits and flexibility provided by hybrid trials. The featured
speakers will explore innovative strategies and address the
challenges associated with hybrid trials.
TORONTO, July 23,
2024 /PRNewswire-PRWeb/ -- Discover an
informative webinar that revolutionizes the impact of hybrid
clinical trials by implementing patient-centric solutions that
fast-track the development of life-changing therapies.
Data show that these approaches are
enhancing efficiency with reduced patient burden, increased patient
retention and greater representative patient population.
Historically, trials necessitated in-person participation,
requiring volunteers to travel to research sites. On an average,
travel times amounted to two hours, excluding the time spent at the
site. Hybrid clinical trials and decentralized clinical
trials are transforming the way that clinical trials are conducted
by giving participants options.
Data show that these approaches are enhancing efficiency with
reduced patient burden, increased patient retention and greater
representative patient population. In this webinar, the expert
speakers explore a range of innovative solutions and key
partnerships essential for successfully conducting hybrid clinical
trials. They will also share insights on how flexible solutions can
propel clinical research forward through the versatility of the
hybrid clinical trial optionality.
Register for this webinar today to explore the future of
clinical trials through patient-centric hybrid clinical trials.
Join Thad Wolfram, President,
EmVenio Research; Raj Sharma, Co-Founder, Health Wizz; and
Tajuana Barron, Vice President of
Project Management, PCM Trials, for the live webinar on
Wednesday, August 14, 2024, at
12pm EDT (9 am
PDT)
For more information, or to register for this event, visit
Advancing Clinical Research Through Hybrid Clinical Trials and
Patient Optionality.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1
(416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/advancing-clinical-research-through-hybrid-clinical-trials-and-patient-optionality-upcoming-webinar-hosted-by-xtalks-302202960.html
SOURCE Xtalks